Recombinant Human PCLAF

Product Specifications

Product Name Alternative

HCV NS5A transactivated protein 9, HCV NS5A-transactivated protein 9, Hepatitis C virus NS5A transactivated protein 9, Hepatitis C virus NS5A-transactivated protein 9, KIAA0101, L5, NS5 ATP9, NS5ATP9, OEATC, OEATC 1, OEATC-1, OEATC1, Overexpressed in anaplastic thyroid carcinoma 1

UniProt

Q15004

Expression Region

1-111

Host

E.Coli

Tag

N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process

Applications

Western Blot, ELISA

Purity

Greater than 90% as determined by SDS-PAGE.

Form

Lyophilized powder

Reconstitution

Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

Molecular Weight

12.1 kDa

Shipping Conditions

4°C with ice bag

Storage Conditions

The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.